KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,428 | +170.4% | 44,928 | +265.9% | 0.00% | – |
| Q2 2023 | $22,348 | -52.3% | 12,279 | 0.0% | 0.00% | – |
| Q1 2023 | $46,844 | -68.6% | 12,279 | -13.8% | 0.00% | – |
| Q1 2021 | $149,000 | -54.8% | 14,239 | -33.8% | 0.00% | – |
| Q4 2020 | $330,000 | +16.6% | 21,525 | +12.1% | 0.00% | – |
| Q3 2020 | $283,000 | -20.1% | 19,198 | +2.7% | 0.00% | -100.0% |
| Q2 2020 | $354,000 | +40.5% | 18,688 | +39.5% | 0.00% | 0.0% |
| Q1 2020 | $252,000 | – | 13,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |